- Home
- SYNX vs CARM Comparison
SYNX vs CARM Comparison
Compare SYNX & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- CARM
- Stock Information
- Founded
- SYNX 2005
- CARM 2016
- Country
- SYNX Israel
- CARM United States
- Employees
- SYNX N/A
- CARM N/A
- Industry
- SYNX
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- CARM Health Care
- Exchange
- SYNX Nasdaq
- CARM Nasdaq
- Market Cap
- SYNX 18.5M
- CARM 17.4M
- IPO Year
- SYNX 2024
- CARM N/A
- Fundamental
- Price
- SYNX $4.46
- CARM $0.44
- Analyst Decision
- SYNX
- CARM Hold
- Analyst Count
- SYNX 0
- CARM 5
- Target Price
- SYNX N/A
- CARM $4.57
- AVG Volume (30 Days)
- SYNX 72.7K
- CARM 277.1K
- Earning Date
- SYNX 10-02-2024
- CARM 11-07-2024
- Dividend Yield
- SYNX N/A
- CARM N/A
- EPS Growth
- SYNX N/A
- CARM N/A
- EPS
- SYNX N/A
- CARM N/A
- Revenue
- SYNX $9,893,000.00
- CARM $20,268,000.00
- Revenue This Year
- SYNX $52.34
- CARM $46.34
- Revenue Next Year
- SYNX N/A
- CARM N/A
- P/E Ratio
- SYNX N/A
- CARM N/A
- Revenue Growth
- SYNX 18.05
- CARM 41.13
- 52 Week Low
- SYNX $2.10
- CARM $0.38
- 52 Week High
- SYNX $6.49
- CARM $2.77
- Technical
- Relative Strength Index (RSI)
- SYNX 63.44
- CARM 37.99
- Support Level
- SYNX $3.80
- CARM $0.42
- Resistance Level
- SYNX $4.69
- CARM $0.48
- Average True Range (ATR)
- SYNX 0.60
- CARM 0.06
- MACD
- SYNX 0.00
- CARM 0.01
- Stochastic Oscillator
- SYNX 36.36
- CARM 18.67
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.